Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.11.2013 | case report | Ausgabe 21-22/2013

Wiener Medizinische Wochenschrift 21-22/2013

Triple-negative breast cancer possibly transforming into malignant melanoma due to targeted therapy? A case report and review of literature

Wiener Medizinische Wochenschrift > Ausgabe 21-22/2013
Birgit Aigner, Prof. Dr. med. Sabine Gisela Plötz, Prof. Dr. med. Gerhard Schaller



Triple-negative breast cancer (TNBC) is characterized by lacking expression of estrogen receptor and progesterone receptor as well as absence of human epidermal growth factor receptor 2 overexpression and is an aggressive clinical phenotype.

Patients and methods

We report the case of a 33-year-old woman who has been treated using a targeted approach for TNBC and developed a malignant melanoma metastasis without any primary.

Results and conclusion

Using targeted therapies, tumors can be treated much more effectively, but up to now, we do not know much about potential adverse reactions. Due to the targeted therapy, tumors may be pressurized for transformation. We call for further investigations to rule out the potential risks of targeted therapy in TNBC. This is the first report of a potential transforming of one tumor entity to another by a targeted therapy.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 21-22/2013

Wiener Medizinische Wochenschrift 21-22/2013 Zur Ausgabe